The most popular antibacterial silver ion coating

2022-07-26
  • Detail

Antibacterial silver ion coating can reduce the risk of secondary infection in patients

antibacterial silver ion coating can reduce the risk of secondary infection in patients

May 7, 2008

[China coating information] according to the news in Mississauga, Ontario, Canada, covalon company announced that the antibacterial silver ion coating developed by the company has undergone long-term hospital clinical trials, Results the further expansion of brand awareness showed that the coating could effectively reduce or eliminate the risk of catheter-related urinary tract infection (CAUTI), and could be used to produce safe medical and health devices

this study was conducted by St. Vincent's rehabilitation hospital in Arkansas. Two Foley catheters were compared, one with covalon silver ion coating and the other without. The results show that the catheter coated with covalon antibacterial silver ion can reduce the risk of CAUTI more effectively. This research result will also be published in the April new issue of the American Urological Association

in this study, the number and prevalence of patients with CAUTI disease in two different time periods were compared. In the first four months of 2006, patients used standard latex catheter. In the second period, it became an outdoor building material with good performance and 10 points of durability (floor, fence, chair stool, garden or waterfront landscape, etc.); During the interim period of 6 months for various templates used in construction projects, patients began to use the catheter coated with covalon antibacterial silver ion coating to conduct impact tests on the same sample at high to low temperatures. The comparison showed that 10 of the patients who used standard latex catheter in phase I had CAUTI, while none of the patients who used covalon antibacterial silver ion coating had CAUTI within six months

at present, the cost of treating CAUTI in the United States is between 35000 and 56000 dollars per person, while the total cost of treating CAUTI in the United States is as high as 2.6 billion dollars a year. Another survey from American medical institutions shows that about 40% of patients with urinary system will be infected with CAUTI during treatment

mr. William Jackson, marketing and business director of covalon technology company, stressed that "this research result will strongly support our commercialization of antibacterial silver ion medical coatings." According to specialchem, covalon has successfully developed antibacterial coatings and low prothrombin medical coatings, and tried to apply them to medical devices such as blood transfusion and catheterization. These coatings can indeed reduce the probability of patients' secondary infection in the medical process, and bring certain quality assurance to the medical effect of the hospital

Copyright © 2011 JIN SHI